British experts have claimed that a new breakthrough in drugs would help skin cancer patients fight back the deadly disease.
The researchers said that seriously ill patients who were given the medication reported spectacular effects.
The breakthrough lets doctors to efficiently reboot a skin cancer patient's immune system by administering drugs ipilimumab (ipi) and anti-PD1s, which are capable of breaking down the resistance-systems of cancer cells.
Yervoy, a cancer drug by Bristol-Myers Squibb Co, has been found capable of extending the lives of patients by up to a decade. A study, involved more than 1,800 cancer patients from 12 trials, reveled that more than fifth (22%) were still alive 3 years after treatment, while and 17% survived 7 years after treatment.
Prof. Peter Johnson, of Cancer Research UK, said it was the beginning of a new era of cancer treatments by rebooting the immune system.
It is a big achievement by the researchers in the ongoing battle against skin cancer. Until now, many patients die within months of diagnosis as there had been no effective cure against the disease.
The findings were presented at the recently-held cancer conference in Amsterdam.
- Ford unveils new 2015 Mustang in its first global launch
- Ford set to unveil its all-new 2015 Mustang --- the first Mustang to be sold globally
- Finnish startup Jolla Oy launches its self-titled Jolla headset in Europe
- HTC to launch dual-SIM variant of flagship HTC One handset in UK
- Nokia quietly unveils Lumia 525 Windows Phone 8 smartphone